Plus   Neg

Stock To Watch- H & R Block

Shares of tax preparation services company H & R Block Inc. (HRB) rose 2.51% on Wednesday before closing at $24.54. The stock has been trading in a range of $22.79- $29.62 in the past one year. The trading volume saw an increase yesterday at $5,172 K compared with the average volume of 3,315 K.

Last week H & R announced that the company is making the year 2020 to "Switch to Block" by offering more options for people to file their taxes. The company's online tax filing platform "Tax Pro Go", launched in 2017 allows people to have their taxes done by a real tax pro without visiting an office.

In December last year, H & R Block had reported revenue growth of 8% in the second quarter to $161 million. Adjusted loss per share, however, widened to $0.85 in the quarter from $0.78 in the corresponding year-ago period.

The company had bought back 7.3 million shares during the first six months of fiscal 2019 for $181.0 million, or $24.75 per share.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Global PC shipments returned to growth in the second quarter of 2020 after seeing a significant decline in the preceding first quarter due to COVID-19 related supply-chain disruptions, according to reports by two research firms. The PC market returned to growth in the quarter as production ramped up and vendors restocked their supplies to near-normal levels. The bankruptcy filing of America's oldest apparel retailer Brooks Brothers has ignited significant interest from potential buyers for the brand. WHP Global and a venture backed by Authentic Brands Group LLC and Simon Property Group, Inc., are reportedly considering bids for the retailer. WHP Global owns the ANNE KLEIN and JOSEPH ABBOUD brands. Sundial Herbal Products has recalled around 65 products, which were misbranded and currently unapproved drugs, the U.S. Food and Drug Administration said in a statement. The recall follows an order by a federal judge in June to stop distributing the company's unapproved new drugs. The affected items include herbal products and dietary supplements.
Follow RTT